Ethicomedicolegal aspects of the COVID-19 health services in preparing regulations and intermediaries for clinical dispute resolution: a systematic review

  • Agus Purwadianto Department of Forensic Medicine and Medicolegal, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia https://orcid.org/0000-0001-6946-8005
  • Ade Firmansyah Sugiharto Department of Forensic Medicine and Medicolegal, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia https://orcid.org/0000-0001-8487-4394
  • Fitri Ambar Sari Forensic Unit, Universitas Indonesia Hospital, Depok, Indonesia https://orcid.org/0000-0002-5771-7366
  • Roberia Faculty of Public Health, Universitas Indonesia, Depok, Indonesia
  • Uud Cahyono Department of Law and Organization, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Yuli Budiningsih Department of Forensic Medicine and Medicolegal, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Denys Putra Alim Department of Forensic Medicine and Medicolegal, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia https://orcid.org/0000-0002-7898-9651
  • Nadia Ulfah Faddila Department of Forensic Medicine and Medicolegal, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia https://orcid.org/0000-0002-1537-3489
Keywords: COVID-19, dispute, ethic and medicolegal regulation, Indonesia, mediator
Abstract viewed: 177 times
PDF downloaded: 82 times
HTML downloaded: 32 times
EPUB downloaded: 72 times

Abstract

BACKGROUND The COVID-19 pandemic has caused many medical, ethical, and medicolegal changes, including constant adjustments in service guidelines. Continuing to revise healthcare regulations and guidelines can potentially cause clinical disputes or medical negligence that require ethical and legal solutions. This study aimed to determine the ethical and medicolegal aspects of the potential factors that cause clinical disputes during the pandemic and provide anticipative solutions to national ethicomedicolegal policies.

METHODS A systematic literature search in PubMed, ScienceDirect, ClinicalKey, and Google Scholar was performed using keywords “clinical dispute,” “ethics,” “medicolegal,” “ethicolegal,” and “COVID-19”. The inclusion criteria were articles that contained information on shortage, justice, ethical distribution in intensive care, the possibility of lawsuits and disputes among stakeholders during the pandemic, and stakeholders’ roles in managing the pandemic. Key evidence was analyzed and synthesized following national ethicomedicolegal policies.

RESULTS We identified 19 articles from the 4 databases. Based on the literature, the main ethicomedicolegal impact of the COVID-19 pandemic appears in 3 aspects: (1) a shortage of fair and ethical intensive care services with fair and ethical distribution efforts, (2) legal protection for medical personnel from legal charges while providing health services during the pandemic, and (3) the government’s role in managing the pandemic together with the stakeholders involved.

CONCLUSIONS Ethicomedicolegal clinical dispute management and its norms require an update, especially when deciding the complexity of COVID-19 service standards. Ethicomedicolegal professionals are needed as intermediaries to manage cases of clinical disputes and to implement fair malpractice criteria in Indonesia.

References

  1. World Health Organization regional Office for Europe. Coronavirus disease (COVID-19) pandemic. Copenhagen: World Health Organization Regional Office for Europe. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov#.

  2. President of the Republic of Indonesia. Decree of the President of the Republic of Indonesia number 12 of 2020 concerning the determination of non-natural disasters spreading of corona virus disease 2019 (COVID-19) as a national disaster [Internet]. 2020. Available from: https://peraturan.bpk.go.id/Home/Details/135718/keppres-no-12-tahun-2020. Indonesian.

  3. President of the Republic of Indonesia. Government Regulation of the Republic of Indonesia number 21 of 2020 concerning large-scale social restrictions in the context of accelerating handling of corona virus disease 2019 (COVID-19) [Internet]. 2020. Available from: https://peraturan.bpk.go.id/Home/Details/135059/pp-no-21-tahun-2020. Indonesian.

  4. President of the Republic of Indonesia. Government Regulation in Lieu of Law of the Republic of Indonesia number 1 of 2020 concerning state financial policy and financial system stability for handling the COVID-19 pandemic and/or in facing threats which endanger the national economy [Internet]. 2020. Available from: https://peraturan.bpk.go.id/Home/Details/135060/perpu-no-1-tahun-2020. Indonesian.

  5. President of the Republic of Indonesia. Decree of the President of the Republic of Indonesia number 11 of 2020 concerning the determination of public health emergency of corona virus disease 2019 (COVID-19) [Internet]. 2020. Available from: https://peraturan.bpk.go.id/Home/Details/135058/keppres-no-11-tahun-2020. Indonesian.

  6. Ministry of Health of the Republic of Indonesia. Guidelines for the prevention and control of coronavirus disease (COVID-19) [Internet]. Jakarta: Directorate General of Disease Prevention and Control; 2020. Available from: https://infeksiemerging.kemkes.go.id/download/KMK_No._HK.01.07-MENKES-413-2020_ttg_Pedoman_Pencegahan_dan_Pengendalian_COVID-19.pdf. Indonesian.

  7. Tolentino VR, Derevlany L, DeLaMothe C, Vick S, Chalyavski L. The effects of the COVID-19 pandemic on risk management practice: a report from the epicenter of the epicenter in New York City. J Healthc Risk Manag. 2021;40(4):46-57. https://doi.org/10.1002/jhrm.21461

  8. Cook T, Gupta K, Dyer C, Fackrell R, Wexler S, Boyes H, et al. Development of a structured process for fair allocation of critical care resources in the setting of insufficient capacity: a discussion paper. J Med Ethics. 2020;47(7):456-63. https://doi.org/10.1136/medethics-2020-106771

  9. Riyanto OS, Ardyantara DM, Wardhana RS, Lungan L. Legal protection for doctors against dishonesty of patients in providing information during COVID-19 pandemic. Int J Sci Technol Manag. 2021;2(1):289-99. https://doi.org/10.46729/ijstm.v2i1.118

  10. Duignan K, Bradbury C. Covid-19 and medical negligence litigation: immunity for healthcare professionals? Med Leg J. 2020;88(1_suppl):31-4. https://doi.org/10.1177/0025817220935892

  11. Riley-Smith Qc T, Heppinstall A, Foster F. Is Covid-19 sowing the seeds for future litigation? Med Leg J. 2020;88(2):90-7. https://doi.org/10.1177/0025817220926943

  12. Marshall AI, Archer R, Witthayapipopsakul W, Sirison K, Chotchoungchatchai S, Sriakkpokin P, et al. Developing a Thai national critical care allocation guideline during the COVID-19 pandemic: a rapid review and stakeholder consultation. Health Res Policy Sys. 2021;19(47). https://doi.org/10.1186/s12961-021-00696-z

  13. Sesta L, Mondello C, Cardia L, Modello E, Baldino G, Spagnolo EV. COVID-19 in Italy. Clinical emergency and bioethical perspectives. EuroMediterranean Biomed J. 2020;15(30):121-5. https://doi.org/10.3269/1970-5492.2020.15.30

  14. Netters S, Dekker N, van de Wetering K, Hasker A, Paasman D, de Groot JW, et al. Pandemic ICU triage challenge and medical ethics. BMJ Support Palliat Care. 2021;11(2):133-7. https://doi.org/10.1136/bmjspcare-2020-002793

  15. Bolcato M, Aurilio MT, Aprile A, Di Mizio G, Della Pietra B, Feola A. Take-home messages from the COVID-19 pandemic: strengths and pitfalls of the Italian National Health Service from a medico-legal point of view. Healthcare (Basel). 2020;9(1):17. https://doi.org/10.3390/healthcare9010017

  16. Mehta AR, Szakmany T, Sorbie A. The medicolegal landscape through the lens of COVID-19: time for reform. J R Soc Med. 2021;114(2):55-9. https://doi.org/10.1177/0141076820974988

  17. Oliva A, Caputo M, Grassi S, Vetrugno G, Marazza M, Ponzanelli G, et al. Liability of health care professionals and institutions during COVID-19 pandemic in Italy: symposium proceedings and position statement. J Patient Saf. 2020;16(4):e299-302. https://doi.org/10.1097/PTS.0000000000000793

  18. Barranco R, Vallega Bernucci Du Tremoul L, Ventura F. Hospital-acquired SARS-Cov-2 infections in patients: inevitable conditions or medical malpractice? Int J Environ Res Public Health. 2021;18(2):489. https://doi.org/10.3390/ijerph18020489

  19. Ferorelli D, Mandarelli G, Solarino B. Ethical challenges in health care policy during COVID-19 pandemic in Italy. Medicina (Kaunas). 2020;56(12):691. https://doi.org/10.3390/medicina56120691

  20. Kumar A, Kapila M, Pankaj R. Medicine and law in the times of COVID-19 pandemic: understanding the interphase. Indian J Crit Care Med. 2020;24(10):971-4. https://doi.org/10.5005/jp-journals-10071-23553

  21. Coghlan N, Archard D, Sipanoun P, Hayes T, Baharlo B. COVID-19: legal implications for critical care. Anaesthesia. 2020;75(11):1517- 28. https://doi.org/10.1111/anae.15147

  22. Bonvicini B, Cecchi R, Parisi SG, Masotti V, Viero A, Cecchetto G, et al. Legal scenarios in the coronavirus time: medico legal implications in the aspects of governance. Leg Med (Tokyo). 2021;48:101832. https://doi.org/10.1016/j.legalmed.2020.101832

  23. Camporesi S, Mori M. Ethicists, doctors and triage decisions: who should decide? And on what basis? J Med Ethics. 2020;47:e18. https://doi.org/10.1136/medethics-2020-106499

  24. Arimany-Manso J, Martin-Fumadó C. [Medico-legal issues regarding from the COVID-19 pandemic]. Med Clin (Barc). 2020;155(8):344-6. English, Spanish. https://doi.org/10.1016/j.medcle.2020.06.014

  25. Kelly AM. COVID-19 and medical litigation: more than just the obvious. Emerg Med Australas. 2020;32(4):703-5. https://doi.org/10.1111/1742-6723.13548

  26. Sugiharto AF, Purwadianto A, Madjid AS, Budiningsih Y. [Distributive justice in intensive care: ethicolegal review in the reposition of doctor-patient treating relationship] [dissertation]. Jakarta: Universitas Indonesia; 2018. Indonesian.

  27. Riva L, Petrini C. Ethics of triage for intensive-care interventions during the COVID-19 pandemic: age or disability related cut-off policies are not justifiable. Clin Ethics. 2021;16(3):228-33. https://doi.org/10.1177/1477750920971803

  28. Gostin LO. Pandemic Influenza: public health preparedness for the next global health emergency. J Law Med Ethics. 2004;32(4):565-73. https://doi.org/10.1111/j.1748-720X.2004.tb01962.x

  29. Xavier F. Disciplinary proceedings in the medical profession: part I. Singapore: Rajah & Tann Publication; 2000.

  30. American Medical Association. COVID-19: recommendations for pursuing liability protections through state action [Internet]. American Medical Association; 2020. Available from: https://www.ama-assn.org/system/files/2020-04/state-guidance-medical-liability-protections.pdf.

  31. Budiningsih Y. [The methodological foundation of ethical decision doctor mediators in preventing and resolving medical dispute] [dissertation]. Jakarta: Universitas Indonesia; 2012. Indonesian.

  32. Brown DK. Criminal procedure entitlements, professionalism, and lawyering norms. SSRN Electronic Journal. 2000;61(2):867-8. https://doi.org/10.2139/ssrn.247337

  33. Kyriakakis J. Developments in international criminal law and the case of business involvement in international crimes. International Review of the Red Cross. 2012;94(887):981-1005. https://doi.org/10.1017/S1816383113000519

Published
2022-04-22
How to Cite
1.
Purwadianto A, Sugiharto AF, Sari FA, Roberia, Cahyono U, Budiningsih Y, Alim DP, Faddila NU. Ethicomedicolegal aspects of the COVID-19 health services in preparing regulations and intermediaries for clinical dispute resolution: a systematic review. Med J Indones [Internet]. 2022Apr.22 [cited 2022May19];31(1):38-9. Available from: https://mji.ui.ac.id/journal/index.php/mji/article/view/5718
Section
Clinical Research